---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-087926"
form_type: "8-K"
ticker: "RLMD"
cik: "0001553643"
company_name: "RELMADA THERAPEUTICS, INC."
filed_at: "2025-09-16T23:59:59+00:00"
generated_at: "2026-05-17T06:29:37.413605+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Relmada regains Nasdaq minimum bid price compliance; stock remains listed on Capital Market

## Summary
- Received Nasdaq written notice on Sept 15, 2025, confirming compliance with $1.00 minimum bid price rule after 10 consecutive trading days.
- Compliance achieved after closing bid price exceeded $1.00 from Aug 29 to Sept 12, 2025; Nasdaq considers matter closed.
- Relmada now fully compliant with all Nasdaq continued listing requirements; RLMD remains traded on Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001213900-25-087926
- form_type: 8-K
- ticker: RLMD
- cik: 0001553643
- company_name: RELMADA THERAPEUTICS, INC.
- filed_at: 2025-09-16T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1553643/000121390025087926/0001213900-25-087926-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1553643/000121390025087926/ea0257497-8k_relmada.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-087926
- JSON: https://secwatch.observer/filing/0001213900-25-087926.json
- Plain text: https://secwatch.observer/filing/0001213900-25-087926.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.